Antifungal susceptibilities and subtype identifications of Candida species, isolated in blood cultures throughout one-year period;Bir yil içerisinde kan kültürlerinden izole edilen candida türlerinin daǧilimi ve antifungal duyarliliklari

Erciyes Tip Dergisi

Volumn 29, Issue 2, 2007, Pages 115-119

  Kuzucu, Çiǧdem ^a   Yetkin, Gülay ^a,b   Çalişkan, Ahmet ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antifungal agents; Candida; Drug resistance; Fungal

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ADULT; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDEMIA; CANDIDIASIS; CATHETERIZATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ENDOTRACHEAL INTUBATION; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; INTENSIVE CARE UNIT; MORTALITY; NONHUMAN;

EID: 34250743089     PISSN: 1300199X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lunel FMV, Meis JFGM, Voss A: Nosocomial Fungal Infections: Candidemia. Diagn Microbiol Infect Dis 1999; 34:213-220.
2. Cheng MF, Yu KW, Tang RB, et al. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999 Diagn Microbiol Infect Dis 2004;48: 33-37.
3. Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, et al. Teutsch SM. Excess Mortality, Hospital Stay, and cost due to Candidemia: A case-control study Using Data From Population-based Candidemia Surveillance. Infect Control Hosp Epidemiol 2005;26: 540-547.
4. Bedini A, Venturelli C, Mussini C, et al. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 2006; 12: 75-80.
5. Baddley JW, Patel M, Jones M, Cloud G, Smith AC, Moser SA. Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia. Diagn Microbiol Infect Dis 2004:50: 119-124.
6. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard-second edition. NWayne, PA: 2002.
7. Bedini A, Venturelli C, Mussini C, et al. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin MicrobiolInfect.2006; 12:75-80.
8. San Miguel LG, Cobo J, Otheo E, Sanchez-Sousa A, Abraira V, Moreno S. Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: Emergence of Candida parapisilosis. Infect Control Hosp Epidemiol 2005;26:548-552.
9. Singhi SC, Reddy T, Chakrabarti A. Candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 2004; 5:369-374.
10. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med 2006; Mar:34:857-863.
11. Ener B, Sinirtaş M, Akalin H, HaciMustafaoǧlu M, Özakin C, Gedikoǧlu S, Töre O, Gökirmak F. Nozokomiyal kandidemi etkenlerinin retrospektif analizi. İnfeksiyon Dergisi 1998 12: 85-88.
12. Pfaller MA, Diekema DJ, the International Fungal Surveillance Participant Group. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 2004; 10 (Suppl.1): 11-23.
13. Pfaller MA, Messer SA, Houston A, et al. National epidemiology of mycoses survey:A multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 1998;31:289-296.
14. Roilides E, Farmaki E, Evdoridou J, et al. Candida tropicalis in a neonatal intensive care unit: Epidemiologic and molecular analysis of infection with an uncommon neonatal pathogen. J Clin Microbiol 2003; 41:735-741.
15. Vrioni G., Matsiota-Bernard P. Molecular typing of Candida isolates from patients hospitalised in an intensive care unit. J Infec 2001;42: 50-56.
16. Bengisun JS, Güriz H, Yavuzdemir Ş, Aysev AD, Palabiyikoǧlu İ. İnvazif infeksiyonlarda Candida türlerinin daǧilimi ve bu türlerde iki farkli antifungal duyarlilik yönteminin karşilaştirilmasi. Türk Mikrobiyoloji Cemiyeti Dergisi 2001; 31:73-77.
17. Leibovitz E. Neonatal candidosis: Clinical picture, management controversies and consensus, and new therapeutic options. J Antimicrob Chemother 2002;49 Suppl 1:69-73.
18. Avila-Aguero ML, Canas-Coto A, Ulloa-Gutierrez R, Caro MA, Alfaro B, Paris MM. Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica. Int J Infect Dis 2005; 9:90-95.
19. Ibanez-Nolla J, Nolla-Salas M, Leon MA, et al. Early diagnosis of candidiasis in non-neutropenic critically inpatients. J Infect 2004; 48: 181-192.
20. Zaoutis TE, Foraker E, McGowan KL, et al. Antifungal susceptibility of Candida spp. Isolated from pediatric patients:A survey of 4 children's hospitals. Diagn Microbiol Infect Dis 2005;52:295-298.
21. Koc AN, Erdem F, Çetin N. Kan kültürlerinden üreyen mayalarin retrospektif olarak deǧerlendirilmesi ve antifungal duyarliliklari. 4. Antimikrobik Kemoterapi Günleri Özet Kitabi, İstanbul 1999:s212.